Study identification

PURI

https://redirect.ema.europa.eu/resource/41916

EU PAS number

EUPAS18732

Study ID

41916

Official title and acronym

The relationship between the month of birth and ADHD treatment

DARWIN EU® study

No

Study countries

Netherlands

Study description

****This study has been cancelled before data collection due to lack of time by the researchers**** There seems to be a relationship between a child’s month of birth and the diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). Both underdiagnosis as well as overdiagnosis of ADHD can have consequences for the future of a child. The objective of this study is to determine if there is a relationship between the month of birth and the pharmacological treatment of ADHD in children in the Netherlands. The study cohort includes children and adolescents ≤ 24 years old who use ADHD medication, dispensed for the first time between 2006-2016.

Study status

Finalised
Research institution and networks

Institutions

Contact details

Rob Heerdink

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Data collection

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Other

More details on funding

Division of Pharmacoepidemiology & Clinical Pharmacology
Study protocol
Initial protocol

20170426 ADHD_birthmonth_def3

English (561.42 KB - PDF)View document
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable